Target intelligence / Profile preview

Rho guanine nucleotide exchange factor 37 (ARHGEF37)

Target
ARHGEF37
Molecular classification
Enzyme, Guanine nucleotide exchange factor
01

Overview

Rho guanine nucleotide exchange factor 37 (ARHGEF37) is a protein-coding gene that encodes a guanine nucleotide exchange factor (GEF), which activates Rho family small GTPases by promoting the exchange of GDP for GTP[1][10]. ARHGEF37 is predicted to be active in the cytoplasm and is implicated in signal transduction pathways, including clathrin-mediated endocytosis, where it assists dynamin 2 at late endocytic sites[6][8]. Genetic variants in ARHGEF37 have been associated with rare diseases such as epidermolysis bullosa simplex 1A and thiamine-responsive megaloblastic anemia syndrome[1]. No drugs are currently known to target ARHGEF37 directly, nor are there established biomarker or safety concerns for therapeutic intervention involving this gene.

Other names
ARHGEF37FLJ41603Rho guanine nucleotide exchange factor (GEF) 37
02

Biological functions

Signal transductionClathrin-mediated endocytosis
03

Disease associations

Epidermolysis bullosa simplex 1AThiamine-responsive megaloblastic anemia syndrome

Beyond the preview

Go deeper on Rho guanine nucleotide exchange factor 37 (ARHGEF37).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho guanine nucleotide exchange factor 37 (ARHGEF37).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call